Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Keffer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|July 27, 2001
Guidelines and algorithms: perceptions of why and when they are successful and how to improve themJ H Keffer
American Journal of Clinical Pathology|October 1, 1995
Economic considerations of point-of-care testingJ H Keffer
Hematology/Oncology Clinics of North America|August 1, 1996
Endocrinopathy and ectopic hormones in malignancyJ H Keffer
American Journal of Clinical Pathology|March 1, 1996
Myocardial markers of injury. Evolution and insightsJ H Keffer
Therapeutic Drug Monitoring|January 1, 1979
Thyroid replacement therapy: a rational approach to laboratory monitoringJ H Keffer
Indian Journal of Clinical Biochemistry : IJCB|October 30, 2012
Biochemical advances in detection of the acute coronary syndromes: Implications for therapeutic decisionsJ H Keffer
American Journal of Clinical Pathology|April 1, 1997
The cardiac profile and proposed practice guideline for acute ischemic heart diseaseJ H Keffer
Pathologist|May 11, 1983
Selecting equipment and reagents: a personal experience and processJ H Keffer
Clinics in Laboratory Medicine|January 24, 1998
Why cardiospecificity is preeminent in myocardial markers of injuryJ H Keffer
Clinical Chemistry|January 1, 1996
Preanalytical considerations in testing thyroid functionJ H Keffer
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|July 27, 2001
Guidelines and algorithms: perceptions of why and when they are successful and how to improve themJ H Keffer
American Journal of Clinical Pathology|October 1, 1995
Economic considerations of point-of-care testingJ H Keffer
Hematology/Oncology Clinics of North America|August 1, 1996
Endocrinopathy and ectopic hormones in malignancyJ H Keffer
American Journal of Clinical Pathology|March 1, 1996
Myocardial markers of injury. Evolution and insightsJ H Keffer
Therapeutic Drug Monitoring|January 1, 1979
Thyroid replacement therapy: a rational approach to laboratory monitoringJ H Keffer
Indian Journal of Clinical Biochemistry : IJCB|October 30, 2012
Biochemical advances in detection of the acute coronary syndromes: Implications for therapeutic decisionsJ H Keffer
American Journal of Clinical Pathology|April 1, 1997
The cardiac profile and proposed practice guideline for acute ischemic heart diseaseJ H Keffer
Pathologist|May 11, 1983
Selecting equipment and reagents: a personal experience and processJ H Keffer
Clinics in Laboratory Medicine|January 24, 1998
Why cardiospecificity is preeminent in myocardial markers of injuryJ H Keffer
Clinical Chemistry|January 1, 1996
Preanalytical considerations in testing thyroid functionJ H Keffer
Pageof 2